Supplementary Figure 1 from Epidermal Growth Factor Receptor–Targeted Radioimmunotherapy of Human Head and Neck Cancer Xenografts Using &lt;sup&gt;90&lt;/sup&gt;Y-Labeled Fully Human Antibody Panitumumab